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fore the identiﬁcation, biological characterization of endogenous Cynomolgus IFN-a
subtypes and their accurate detection are of utmost importance for predicting the
clinical outcome of effective human therapeutics. We have isolated full length IFN-
a coding sequences from Cynomolgus genomic DNA using PCR methods. Sequence
analysis revealed 11 unique IFN-a subtypes which were transiently expressed in Vero
cells. The conditioned supernatants were tested in parallel with puriﬁed, E. coli pro-
duced Cynomolgus IFN-a2 for accurate quantitation. All samples tested on Cynomol-
gus cells exhibited strong antiviral activity. Additionally, the biological activities of
the IFN proteins secreted in the tissue culture supernatants were characterized in sev-
eral human cell-based assays including A549/EMCV cytopathic protective effect, OV-
CAR-3 antiproliferative and caspase-3/7 activation assays. All subtypes displayed
activity on these separate human cell lines suggesting reasonable species cross-reac-
tivity. Analysis in a human IFN-a ELISA further supported these observations. Sepa-
rately, we analyzed the activity in a human cell-based reporter assay (iLiteTM Human
IFN-a Kit) including the use of an anti-IFN-a receptor neutralizing antibody. This as-
say correlated with the other human cell-based assays, providing an additional, more
rapid measure of activity. Moreover, the activity could be potently neutralized by the
anti-human IFNAR monoclonal antibody further suggesting similarities between
Cynomolgus and human IFN-a receptor proteins. Therefore these reagents should
prove useful in the detection and biological evaluation of Cynomolgus IFN-a proteins
used for the better understanding of human viral diseases and their treatments.
doi:10.1016/j.cyto.2008.07.289
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SOCS proteins play a critical role in the negative feedback inhibition of cytokine
signal transduction pathways. SOCS protein contain a C-terminal SOCS box domain.
A similar SOCS box domain is found at the C-terminus of over 70 human proteins.
The SOCS box domain is usually coupled to protein interaction module(s) that interact
with a protein target. The SOCS box can interact with elongin and cullin molecules,
leading to formation of an E3 ligase complex and proteasomal degradation of the tar-
get. In this way, SOCS proteins can direct activated cytokine receptor complexes to
proteasomal degradation. We recently demonstrated that the SOCS box of SOCS pro-
teins is implicated in the interaction of all SOCS proteins with SOCS2, 6 and 7. This
interaction can lead to degradation of the targeted SOCS protein. SOCS2, 6 and 7
are thus able to control degradation of other SOCS proteins. We further demonstrated
that the interaction of Cis with its substrate is critically dependent upon the integrity
of its SOCS box and its interaction with elongins. The SOCS box thus emerges as a ver-
satile module controlling cytokine signaling via multiple mechanisms.
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Binding of human Interleukin-6 (IL-6) to its speciﬁc receptor IL-6R is a prere-
quisite for the activation of the signal transducing receptor glycoprotein 130
(gp130).IL-6 binds to the IL-6R via site I and makes contact to gp130 via site II
and site III. The mode of assembly and the stochiometry of the signalling complex
is not completely understood. We have used two different models to shed more
light on the molecular make-up of the signalling IL-6R complex. In the ﬁrst model
we have analyzed the viral IL-6 (vIL-6) protein from Human herpes virus 8which
unlike human IL-6 can bind to gp130 directly. We have identiﬁed the amino acids
within vIL-6, which are responsible for direct binding to gp130 and we show that
these amino acids when transferred into the human IL-6 protein also render human
IL-6 independent of the IL-6R. In the second model we have identiﬁed amino acid
residues within the gp130 molecule, which are of particular importance for binding
to the IL-6/IL-6R complex. We have identiﬁed three amino acids, which, when
mutated, give rise to gp130 molecules with higher binding afﬁnities. Surprisingly,
amino acids within vIL-6, important for direct gp130 binding and amino acids gov-
erning gp130 binding to the IL-6/IL-6R lie within site III, which has previously been
thought to be responsible for the dimerization of two preassembled IL-6/IL-6R/
gp130 trimers. We believe that the importance of site III for the assembly of the
IL-6 receptor complex is underestimated and we will present an alternative model
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Extensive clinical studies have established a direct correlation between num-
bers of red cells present in the blood and the concentration of erythropoietin.
Erythropoietin interacts with a speciﬁc receptor, EPO-R, on the surface of erythroid
cells. In the mouse, in addition to EPO and EPO-R, the glucocorticoid receptor (GR)
controls erythropoiesis following stress. It is generally accepted that glucocorticoids
enter cells and interact with GR within the cytoplasm. This binding induce receptor
dimerization, STAT-5-phosphorylation and formation of GR/STAT-5 complexes, that
migrate to the nucleus, bind to speciﬁc consensus sequences and activate the
expression of target genes. In erythroid cells, GR stimulation regulates the expres-
sion of a subset of genes associated with induction of proliferation. Recent evi-
dence indicates the existence of rapid glucocorticoid signalling mediated by
membrane associated receptors. The possibility that GR might be associated with
the plasma membrane of erythroid cells has not been investigated to date. In this
study we describe a new biochemical pathway that might contribute to the revers-
ible inhibition exerted by glucocorticoids on erythroid maturation and that may
contribute to the genesis of polycythemia vera (PV). We show that dexamethasone
antagonizes the effects of erythropoietin on maturation, but not on survival, of
human proerythroblasts. While erythropoietin and dexamethasone alone induce
STAT-5-phosphorylation, the combination was ineffective in promoting STAT-5-
phosphorylation in normal erythroblasts. By contrast, STAT-5-phosphorylation
was observed in erythroblasts from PV patients stimulated with erythropoietin
and dexamethasone in combination. Growth factor deprivation induced signiﬁcant
levels of STAT-5-phosphorylation in erythroblasts from normal subjects and from
PV patients. A signiﬁcant correlation exists between levels of STAT-5-phosphoryla-
tion induced by growth factor deprivation and numbers of proerythroblasts gener-
ated in vitro from different donors. These data suggest that glucocorticoids
interfere with EPO-induced maturation by antagonizing the STAT-5-phosphoryla-
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S100A12 is considered a DAMP thought to exert proinﬂammatory functions
through ligation of RAGE1. Earlier experiments were based on effects of bovine
S100A12 on BV-2 cells (murine microglial cells)1. Monocytes and THP-1 cells
express RAGE. Using a homologous system, we assessed 9 batches of LPS-free
recombinant S100A12, but found no induction of IL-1b, IL-6, IL-8 or TNF in
PBMCs, or of IL-8 by undifferentiated/differentiated THP-1 cells. Although we
showed that S100A12 undergoes structural changes with zinc, to form quatra-
mers and hexamers, zinc did not alter the inability of S100A12 to activate mono-
cytes. S100A12 is chemotactic for monocytes and mast cells (MC), induces MC
degranulation and MC-dependent inﬂammation in vivo. Responses were partially
blocked by sRAGE, a RAGE antagonist, although MC did not express RAGE mRNA
or protein, suggesting an alternate receptor. S100A12 provoked chemotaxis of
THP-1 cells in a biphasic manner, with optimal concentrations at 10–9 and
10–12 M; both were pertussis toxin sensitive. sRAGE only reduced migration of
THP-1 cells in response to 10-9 M S100A12. PD98059, a selective ERK1/2 inhib-
itor which reduces RAGE-mediated responses, did not affect S100A12-mediated
THP-1 cell migration at either concentration. Thus monocytes and MC may share
a common G-protein coupled receptor that mediates S100A12-induced chemo-
taxis. These results suggest that the ‘RAGE/S100 proinﬂammatory axis’ theory
should be re-evaluated. Because S100A12 binds zinc we investigated its inﬂuence
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